Terms: = Ovarian cancer AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776 AND Prognosis
12 results:
1. PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer.
Chen B; Lu X; Zhou Q; Chen Q; Zhu S; Li G; Liu H
PLoS One; 2023; 18(8):e0290031. PubMed ID: 37582104
[TBL] [Abstract] [Full Text] [Related]
2. prognosis Trend of Grade 2 Endometrioid Endometrial Carcinoma: Toward Grade 1 or 3?
Khatib G; Gulec UK; Guzel AB; Bagir E; Paydas S; Vardar MA
Pathol Oncol Res; 2020 Oct; 26(4):2351-2356. PubMed ID: 32488809
[TBL] [Abstract] [Full Text] [Related]
3. Impact of uterus-preserving surgery on Stage I primary mucinous epithelial ovarian carcinoma: A multi-institutional study with propensity score-weighted analysis.
Yoshihara M; Kajiyama H; Tamauchi S; Iyoshi S; Yokoi A; Suzuki S; Kawai M; Nagasaka T; Takahashi K; Matsui S; Kikkawa F
Int J Gynaecol Obstet; 2020 Aug; 150(2):177-183. PubMed ID: 32469080
[TBL] [Abstract] [Full Text] [Related]
4. Higher platelet distribution width is associated with unfavorable prognosis in ovarian cancer.
Qin L; Li JY; Huang WJ; Zhang ML; Wang RT; Shen W
Cancer Biomark; 2020; 28(3):365-370. PubMed ID: 32417761
[TBL] [Abstract] [Full Text] [Related]
5. Radiogenomics of High-Grade Serous ovarian cancer: Multireader Multi-Institutional Study from the cancer Genome Atlas ovarian cancer Imaging Research Group.
Vargas HA; Huang EP; Lakhman Y; Ippolito JE; Bhosale P; Mellnick V; Shinagare AB; Anello M; Kirby J; Fevrier-Sullivan B; Freymann J; Jaffe CC; Sala E
Radiology; 2017 Nov; 285(2):482-492. PubMed ID: 28641043
[TBL] [Abstract] [Full Text] [Related]
6. Long Noncoding RNA LINC00092 Acts in cancer-Associated Fibroblasts to Drive Glycolysis and Progression of ovarian cancer.
Zhao L; Ji G; Le X; Wang C; Xu L; Feng M; Zhang Y; Yang H; Xuan Y; Yang Y; Lei L; Yang Q; Lau WB; Lau B; Chen Y; Deng X; Yao S; Yi T; Zhao X; Wei Y; Zhou S
Cancer Res; 2017 Mar; 77(6):1369-1382. PubMed ID: 28087599
[TBL] [Abstract] [Full Text] [Related]
7. Expressions of CD44,CD47,and c-met in ovarian Clear Cell Carcinoma and Their Clinical Significance.
Wang HM; Tan MZ; Zhang S; Li X; Gao J; Zhang DY; Hao YY; Gao S; Liu JJ; Lin B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Dec; 38(6):720-725. PubMed ID: 28065241
[TBL] [Abstract] [Full Text] [Related]
8. Computational and Immunohistochemical Analyses Highlight AXL as a Potential Prognostic Marker for ovarian cancer Patients.
Lozneanu L; Pinciroli P; Ciobanu DA; Carcangiu ML; Canevari S; Tomassetti A; Căruntu ID
Anticancer Res; 2016 Aug; 36(8):4155-63. PubMed ID: 27466525
[TBL] [Abstract] [Full Text] [Related]
9. Pyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal Leiomyosarcoma.
González-Alonso P; Chamizo C; Moreno V; Madoz-Gúrpide J; Carvajal N; Daoud L; Zazo S; Martín-Aparicio E; Cristóbal I; Rincón R; García-Foncillas J; Rojo F
Int J Mol Sci; 2015 Aug; 16(8):19447-57. PubMed ID: 26287187
[TBL] [Abstract] [Full Text] [Related]
10. Expression and significance of CD44, CD47 and c-met in ovarian clear cell carcinoma.
Wang H; Tan M; Zhang S; Li X; Gao J; Zhang D; Hao Y; Gao S; Liu J; Lin B
Int J Mol Sci; 2015 Feb; 16(2):3391-404. PubMed ID: 25658794
[TBL] [Abstract] [Full Text] [Related]
11. Improved survival for stage IIIC ovarian cancer patients treated at the Norwegian Radium Hospital between 1984 and 2001.
Oksefjell H; Sandstad B; Tropé C
Eur J Gynaecol Oncol; 2007; 28(4):256-62. PubMed ID: 17713088
[TBL] [Abstract] [Full Text] [Related]
12. Synchronous primary neoplasms of the female reproductive tract.
Eisner RF; Nieberg RK; Berek JS
Gynecol Oncol; 1989 Jun; 33(3):335-9. PubMed ID: 2722060
[TBL] [Abstract] [Full Text] [Related]
